To confirm Sp1 binding to GPER1 promoter in MM cells, we carried out a ChIP assay using Sp1 antibodies in the presence of G-1 or a vehicle, which confirmed the binding of Sp1 to GPER promoter, conversely reduced after G-1 treatment (Figure 4A). Here, SP1 is linked to Miyoshi myopathy.